Werba Rubin Papier Wealth Management Gilead Sciences, Inc. Transaction History
Werba Rubin Papier Wealth Management
- $426 Billion
- Q3 2024
A detailed history of Werba Rubin Papier Wealth Management transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Werba Rubin Papier Wealth Management holds 14,095 shares of GILD stock, worth $1.24 Million. This represents 0.28% of its overall portfolio holdings.
Number of Shares
14,095
Previous 13,728
2.67%
Holding current value
$1.24 Million
Previous $942 Million
25.46%
% of portfolio
0.28%
Previous 0.26%
Shares
5 transactions
Others Institutions Holding GILD
# of Institutions
1,924Shares Held
994MCall Options Held
10.5MPut Options Held
9.75M-
Black Rock Inc. New York, NY121MShares$10.6 Billion0.19% of portfolio
-
Vanguard Group Inc Valley Forge, PA115MShares$10.1 Billion0.18% of portfolio
-
Capital World Investors Los Angeles, CA76.5MShares$6.72 Billion1.03% of portfolio
-
Capital Research Global Investors Los Angeles, CA61.8MShares$5.42 Billion1.12% of portfolio
-
State Street Corp Boston, MA60.2MShares$5.28 Billion0.21% of portfolio
About GILEAD SCIENCES, INC.
- Ticker GILD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,253,369,984
- Market Cap $110B
- Description
- Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...